6 Papers
Guangming Yi is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis
Mengzhen Yuan,Jun Zhang,Yuxin He,Guangming Yi,Liwen Rong,Lian He Zheng,Tingting Zhan +6 more
TL;DR: Promoting TNBC progression by enhancing proliferation, survival, migration, invasion, and glutamine metabolism via miR-876-3p/SLC1A5 axis, which was helpful for understanding the carcinogenic roles of circ_0062558.
10
BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis
Qian Yu,Yitian Wang,Guangming Yi,Wendi Yang,Kehong Chen,Xiang Yee Tan,Xiaoyue Zhang,Zaicheng Xu,Zhenzhou Yang,Yuan Peng +9 more
TL;DR: It is demonstrated that BDNF serves as an independent potential prognostic marker and correlates with brain metastasis in LUAD, and may be a promising immune-related biomarker and molecular target in patients with LUAD.
4
Retracted Article: Down-regulation of the radiation-induced pEGFRThr654 mediated activation of DNA-PK by Cetuximab in cervical cancer cells
TL;DR: Radiotherapy combined with Cetuximab had a better effect than Gefitinib on attenuating the radio resistance in cervical squamous carcinoma cells via inhibiting pEGFRThr654-mediated nuclear EGFR transport and related DNA-PKT2609-mediated DNA repair.
Visualization and analysis of the impinging spray and combustion characteristics in a lateral swirl combustion system (LSCS)
TL;DR: In this article , a lateral swirl combustion system (LSCS) was proposed to improve the fuel/air mixing and combustion processes, and previous results have validated its excellent combustion performance in direct injection diesel engines.
Genomic features and its potential implication in bone oligometastatic NSCLC
TL;DR: In this article , the genomic landscape of bone oligometastatic non-small cell lung cancer (NSCLC) patients was investigated by collecting paired blood and tissue samples from 31 patients to make a comprehensive analysis of mutations by performing next-generation sequencing.